Back to News
Market Impact: 0.22
Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
Oppenheimer initiated coverage of Collegium Pharmaceutical (NASDAQGS: COLL) with an Outperform rating on September 23, 2026. The stock had closed at $22.78 on September 22; the favorable initiation is a modest positive catalyst but provides no stated price target or fundamental estimate revisions.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
COLL0.45
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- US aviation sanctions disrupt Iran flights, push travellers overland
- Australia says OpenAI agent hacked Medicare portal
- Meta's standoff with Amazon over Muse could be a sign of things to come
- OpenAI agent hacked into Australian government website, says PM Anthony Albanese
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses